182 related articles for article (PubMed ID: 35923559)
1. Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15-34 years of age: A nationwide register-based study.
Niemeyer Hultstrand J; Gemzell-Danielsson K; Kallner HK; Lindman H; Wikman P; Sundström-Poromaa I
Lancet Reg Health Eur; 2022 Oct; 21():100470. PubMed ID: 35923559
[TBL] [Abstract][Full Text] [Related]
2. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
3. There is no association between combined oral hormonal contraceptives and depression: a Swedish register-based cohort study.
Lundin C; Wikman A; Lampa E; Bixo M; Gemzell-Danielsson K; Wikman P; Ljung R; Sundström Poromaa I
BJOG; 2022 May; 129(6):917-925. PubMed ID: 34837324
[TBL] [Abstract][Full Text] [Related]
4. Contemporary hormonal contraception and risk of endometrial cancer in women younger than age 50: A retrospective cohort study of Danish women.
Iversen L; Fielding S; Lidegaard Ø; Hannaford PC
Contraception; 2020 Sep; 102(3):152-158. PubMed ID: 32592798
[TBL] [Abstract][Full Text] [Related]
5. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby A; Hussain M; Rishworth JR; Rees MC
Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
[TBL] [Abstract][Full Text] [Related]
6. Hormonal contraceptive use and risk of pancreatic cancer-A cohort study among premenopausal women.
Butt SA; Lidegaardi Ø; Skovlund C; Hannaford PC; Iversen L; Fielding S; Mørch LS
PLoS One; 2018; 13(10):e0206358. PubMed ID: 30376560
[TBL] [Abstract][Full Text] [Related]
7. Hormonal and intrauterine methods for contraception for women aged 25 years and younger.
Krashin J; Tang JH; Mody S; Lopez LM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD009805. PubMed ID: 26280888
[TBL] [Abstract][Full Text] [Related]
8. Contemporary Hormonal Contraception and the Risk of Breast Cancer.
Mørch LS; Skovlund CW; Hannaford PC; Iversen L; Fielding S; Lidegaard Ø
N Engl J Med; 2017 Dec; 377(23):2228-2239. PubMed ID: 29211679
[TBL] [Abstract][Full Text] [Related]
9. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
10. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
[TBL] [Abstract][Full Text] [Related]
11. Hormonal Contraceptive Use and Risk of Depression Among Young Women With Attention-Deficit/Hyperactivity Disorder.
Lundin C; Wikman A; Wikman P; Kallner HK; Sundström-Poromaa I; Skoglund C
J Am Acad Child Adolesc Psychiatry; 2023 Jun; 62(6):665-674. PubMed ID: 36332846
[TBL] [Abstract][Full Text] [Related]
12. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
Naessen T; Olsson SE; Gudmundson J
Contraception; 1995 Jul; 52(1):35-9. PubMed ID: 8521712
[TBL] [Abstract][Full Text] [Related]
13. A case-control study of breast cancer and hormonal contraception in Costa Rica.
Lee NC; Rosero-Bixby L; Oberle MW; Grimaldo C; Whatley AS; Rovira EZ
J Natl Cancer Inst; 1987 Dec; 79(6):1247-54. PubMed ID: 2961909
[TBL] [Abstract][Full Text] [Related]
14. Long-acting hormonal contraceptives for women.
Garza-Flores J; Hall PE; Perez-Palacios G
J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
[TBL] [Abstract][Full Text] [Related]
15. Association of Hormonal Contraception With Depression.
Skovlund CW; Mørch LS; Kessing LV; Lidegaard Ø
JAMA Psychiatry; 2016 Nov; 73(11):1154-1162. PubMed ID: 27680324
[TBL] [Abstract][Full Text] [Related]
16. Cyclical progestogens for heavy menstrual bleeding.
Bofill Rodriguez M; Lethaby A; Low C; Cameron IT
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD001016. PubMed ID: 31425626
[TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel-releasing intrauterine system and breast cancer risk: A systematic review and meta-analysis.
Conz L; Mota BS; Bahamondes L; Teixeira Dória M; Françoise Mauricette Derchain S; Rieira R; Sarian LO
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):970-982. PubMed ID: 31990981
[TBL] [Abstract][Full Text] [Related]
18. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
[TBL] [Abstract][Full Text] [Related]
19. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
[TBL] [Abstract][Full Text] [Related]
20. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
